Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taishan Hu

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
ACS Infectious Diseases|January 26, 2018
Discovery of Small Molecule Therapeutics for Treatment of Chronic HBV InfectionSong Feng, Lu Gao, Xingchun Han, et al.
ACS Medicinal Chemistry Letters|September 16, 2014
Structure-Based Design and Synthesis of Potent Cyclic Peptides Inhibiting the YAP-TEAD Protein-Protein InteractionZhisen Zhang, Zhaohu Lin, Zheng Zhou, et al.
Journal of Medicinal Chemistry|October 6, 2023
Discovery of 4,5,6,7-Tetrahydropyrazolo[1.5-a]pyrizine Derivatives as Core Protein Allosteric Modulators (CpAMs) for the Inhibition of Hepatitis B VirusBuyu Kou, Zhisen Zhang, Xingchun Han, et al.
Scientific Reports|February 17, 2017
Heteroaryldihydropyrimidine (HAP) and Sulfamoylbenzamide (SBA) Inhibit Hepatitis B Virus Replication by Different Molecular MechanismsZheng Zhou, Taishan Hu, Xue Zhou, et al.
Journal of Medicinal Chemistry|March 10, 2023
Discovery of Linvencorvir (RG7907), a Hepatitis B Virus Core Protein Allosteric Modulator, for the Treatment of Chronic HBV InfectionWeixing Zhang, Lei Guo, Haixia Liu, et al.
Cell Reports|June 25, 2020
Small Molecule Dysregulation of TEAD Lipidation Induces a Dominant-Negative Inhibition of Hippo Pathway SignalingJeffrey K Holden, James J Crawford, Cameron L Noland, et al.
Journal of Medicinal Chemistry|March 25, 2017
Discovery and Pre-Clinical Characterization of Third-Generation 4-H Heteroaryldihydropyrimidine (HAP) Analogues as Hepatitis B Virus (HBV) Capsid InhibitorsZongxing Qiu, Xianfeng Lin, Weixing Zhang, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
ACS Infectious Diseases|January 26, 2018
Discovery of Small Molecule Therapeutics for Treatment of Chronic HBV InfectionSong Feng, Lu Gao, Xingchun Han, et al.
ACS Medicinal Chemistry Letters|September 16, 2014
Structure-Based Design and Synthesis of Potent Cyclic Peptides Inhibiting the YAP-TEAD Protein-Protein InteractionZhisen Zhang, Zhaohu Lin, Zheng Zhou, et al.
Journal of Medicinal Chemistry|October 6, 2023
Discovery of 4,5,6,7-Tetrahydropyrazolo[1.5-a]pyrizine Derivatives as Core Protein Allosteric Modulators (CpAMs) for the Inhibition of Hepatitis B VirusBuyu Kou, Zhisen Zhang, Xingchun Han, et al.
Scientific Reports|February 17, 2017
Heteroaryldihydropyrimidine (HAP) and Sulfamoylbenzamide (SBA) Inhibit Hepatitis B Virus Replication by Different Molecular MechanismsZheng Zhou, Taishan Hu, Xue Zhou, et al.
Journal of Medicinal Chemistry|March 10, 2023
Discovery of Linvencorvir (RG7907), a Hepatitis B Virus Core Protein Allosteric Modulator, for the Treatment of Chronic HBV InfectionWeixing Zhang, Lei Guo, Haixia Liu, et al.
Cell Reports|June 25, 2020
Small Molecule Dysregulation of TEAD Lipidation Induces a Dominant-Negative Inhibition of Hippo Pathway SignalingJeffrey K Holden, James J Crawford, Cameron L Noland, et al.
Journal of Medicinal Chemistry|March 25, 2017
Discovery and Pre-Clinical Characterization of Third-Generation 4-H Heteroaryldihydropyrimidine (HAP) Analogues as Hepatitis B Virus (HBV) Capsid InhibitorsZongxing Qiu, Xianfeng Lin, Weixing Zhang, et al.
Pageof 3